Healthcare provider profile · identity verified

William A Fife, MD

Family Practice · LANCASTER, PA · NPI 1124070933

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	342	76
Omeprazole	Omeprazole	205	41
Amlodipine Besylate	Amlodipine Besylate	174	37
Famotidine	Famotidine	152	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	146	25
Losartan Potassium	Losartan Potassium	127	25
Jardiance	Empagliflozin	122	18
Ozempic	Semaglutide	116	18
Albuterol Sulfate Hfa	Albuterol Sulfate	111	32
Gabapentin	Gabapentin	108	16
Metformin Hcl Er	Metformin Hcl	106	21
Fluticasone Propionate	Fluticasone Propionate	101	32
Trulicity	Dulaglutide	100	22
Carvedilol	Carvedilol	98	17
Mirtazapine	Mirtazapine	97	15
Metformin Hcl	Metformin Hcl	92	19
Lisinopril	Lisinopril	89	23
Diclofenac Sodium	Diclofenac Sodium	87	19
Pantoprazole Sodium	Pantoprazole Sodium	84	14
Allopurinol	Allopurinol	83	13
Montelukast Sodium	Montelukast Sodium	83	17
Levothyroxine Sodium	Levothyroxine Sodium	82	17
Triamcinolone Acetonide	Triamcinolone Acetonide	69	22
Rosuvastatin Calcium	Rosuvastatin Calcium	68	18
Azelastine Hcl	Azelastine Hcl	65	15
Duloxetine Hcl	Duloxetine Hcl	64	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	63	suppressed
Ropinirole Hcl	Ropinirole Hcl	59	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	57	suppressed
Pregabalin	Pregabalin	55	suppressed
Spironolactone	Spironolactone	55	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	55	11
Metoprolol Succinate	Metoprolol Succinate	54	13
Tramadol Hcl	Tramadol Hcl	54	suppressed
Triumeq	Abacavir/Dolutegravir/Lamivudi	53	suppressed
Clonazepam	Clonazepam	52	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	51	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	50	suppressed
Chlorthalidone	Chlorthalidone	49	suppressed
Eliquis	Apixaban	45	suppressed
Furosemide	Furosemide	44	11
Dulera	Mometasone/Formoterol	43	suppressed
Ezetimibe	Ezetimibe	43	suppressed
Finasteride	Finasteride	43	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	suppressed
Ketoconazole	Ketoconazole	43	suppressed
Oxycodone Hcl	Oxycodone Hcl	43	suppressed
Mounjaro	Tirzepatide	40	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	38	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	37	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	suppressed
Xarelto	Rivaroxaban	36	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	suppressed
Doxepin Hcl	Doxepin Hcl	35	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	35	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	34	suppressed
Lamotrigine	Lamotrigine	34	suppressed
Januvia	Sitagliptin Phosphate	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Alprazolam	Alprazolam	29	suppressed
Ammonium Lactate	Ammonium Lactate	29	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	29	suppressed
Humalog Kwikpen U-100	Insulin Lispro	29	suppressed
Lactulose	Lactulose	29	suppressed
Sertraline Hcl	Sertraline Hcl	28	suppressed
Valacyclovir	Valacyclovir Hcl	28	suppressed
Lidocaine	Lidocaine	27	suppressed
Pravastatin Sodium	Pravastatin Sodium	27	11
Valsartan	Valsartan	27	suppressed
Aripiprazole	Aripiprazole	26	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	25	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Ondansetron Odt	Ondansetron	25	suppressed
Potassium Chloride	Potassium Chloride	25	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Baclofen	Baclofen	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Linzess	Linaclotide	24	suppressed
Mupirocin	Mupirocin	24	suppressed
Rybelsus	Semaglutide	24	suppressed
Simvastatin	Simvastatin	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	suppressed
Novolog Flexpen	Insulin Aspart	22	suppressed
Trazodone Hcl	Trazodone Hcl	22	suppressed
Xtampza Er	Oxycodone Myristate	22	suppressed
Cabenuva	Cabotegravir/Rilpivirine	21	suppressed
Emtricitabine-Tenofovir Disop	Emtricitabine/Tenofovir (Tdf)	21	suppressed
Isentress	Raltegravir Potassium	21	suppressed
Premarin	Estrogens, Conjugated	21	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	20	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Celecoxib	Celecoxib	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Loperamide	Loperamide Hcl	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Complera	Emtricita/Rilpivirine/Tenof Df	19	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	19	suppressed
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	19	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Odefsey	Emtricitab/Rilpiviri/Tenof Ala	18	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	17	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	17	suppressed
Juluca	Dolutegravir/Rilpivirine	17	suppressed
Levemir Flexpen	Insulin Detemir	17	suppressed
Meloxicam	Meloxicam	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Icosapent Ethyl	Icosapent Ethyl	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Topiramate	Topiramate	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Prazosin Hcl	Prazosin Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Estradiol	Estradiol	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Methadone Hcl	Methadone Hcl	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Perphenazine	Perphenazine	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Ingrezza	Valbenazine Tosylate	12	suppressed
Naproxen	Naproxen	12	suppressed
Prednisone	Prednisone	12	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Stribild	Elviteg/Cob/Emtri/Tenofo Disop	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Austedo Xr	Deutetrabenazine	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error